Skin lupus can progress more rapidly than previously thoughtSystemic disease among patients with discoid lupus erythematosus, a chronic form of cutaneous lupus, can develop within one to two years of initial diagnosis, says Joseph F. Merola, M.D., reporting at the American Academy of Dermatology annual meeting in San Diego.
Weigh the risk vs benefit of vaccines in autoinflammatory diseasePhysicians should be cautious when administering vaccines, particularly pneumococcal vaccines, to patients with autoinflammatory disorders, according to a new study.
Limp raises suspicion for juvenile arthritisThere are a number of entities to consider in the differential diagnosis when a child presents with a limp, including autoimmune diseases, musculoskeletal disorders, infection, and cancer. Here's why juvenile arthritis is high on the list.
Diagnosing and treating Sjögren's syndrome
Diagnosing and treating Sjögren's syndromeSjögren’s syndrome is underdiagnosed and seriously impacts the ocular surface and quality of life and places the patient at risk for multisystem involvement. Optometry’s role in identification, diagnosis and collaborative long-term management is an important one. Earlier attention to symptoms leading to diagnosis and collaboration with other health professionals will ensure better quality of life for our patients.
Rheumatology for the dermatologist
Rheumatology for the dermatologistThe signs and symptoms of some dermatologic and rheumatologic diseases sometimes overlap, and a better understanding of their associations and subsequent clinical and laboratory evaluations can help in optimizing the treatment and management of this patient population.
Physicians unite to treat psoriatic arthritisMany psoriasis patients develop psoriatic arthritis. Dermatologists should be on the lookout for arthritis symptoms and refer patients to rheumatologists when appropriate.
Scleroderma patients with pulmonary problems face higher mortality riskA new study strongly links pulmonary complications to survival rates among scleroderma patients.
RHEUMATOLOGY: Evaluating potential rheumatic diseasesLaboratory tests are not very helpful when trying to determine whether a child with musculoskeletal complaints has any of the rheumatic diseases of childhood, and using adult models to evaluate these children is equally ineffective.
Joint committee updates criteria for sclerodermaUpdated classification criteria for scleroderma should allow for earlier identification and treatment of the autoimmune disease.
New drug promising for psoriatic arthritisAn oral phosphodiesterase 4 inhibitor may offer significant improvement in signs and symptoms of psoriatic arthritis, according to preliminary trial data presented at the American College of Rheumatology annual meeting in Washington.